Literature DB >> 11316283

Basic fibroblast growth factor induced angiogenesis and prefabricated flap survival.

M J Haws1, D Erdman, S Bayati, R E Brown, R C Russell.   

Abstract

Prefabrication of a latissimus dorsi myocutaneous flap was performed in adult male Landrace pigs. Gelfoam sponges were used as a delivery system for basic fibroblast growth factor (bFGF) at the muscle-subcutaneous tissue interface. Skin survival and angiogenesis were augmented in the growth-factor-treated animals. These data support the use of basic fibroblast growth factor to enhance flap prefabrication.

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11316283     DOI： 10.1055/s-2001-12687

Source DB:  PubMed          Journal:  J Reconstr Microsurg        ISSN： 0743-684X            Impact factor:   2.873


  2 in total

1.  Bioactive nanoparticle-based formulations increase survival area of perforator flaps in a rat model.

Authors:  Ioana Lese; David Alexander Graf; Catherine Tsai; Adriano Taddeo; Martin Tobias Matter; Mihai A Constantinescu; Inge Katrin Herrmann; Radu Olariu
Journal:  PLoS One       Date:  2018-11-26       Impact factor: 3.240

2.  Local injection of deferoxamine improves neovascularization in ischemic diabetic random flap by increasing HIF-1α and VEGF expression.

Authors:  Chen Wang; Yuanyuan Cai; Yun Zhang; Zhuyou Xiong; Guangzao Li; Lei Cui
Journal:  PLoS One       Date:  2014-06-25       Impact factor: 3.240
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.